SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: JOHN W. who wrote (3461)1/7/1998 10:06:00 PM
From: billkirn  Respond to of 6136
 
John: I do think there is more risk since Big Daddy is not footing the R&D bills, and there could be more reward. My overall view for the future (3-5yrs) of AGPH is extremely bright. I still expect to see this stock around 300 in 2002, but many things need to go right.

This short term stuff is much harder to play and I may stop trying to predict its price, but it is hard to resist doing so. I'm in for the long haul and that is where the real money will be made.
Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News